BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+15.25%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$133M
AUM Growth
+$133M
Cap. Flow
+$4.07M
Cap. Flow %
3.05%
Top 10 Hldgs %
72.54%
Holding
56
New
1
Increased
8
Reduced
3
Closed
2

Top Buys

1
PRTA icon
Prothena Corp
PRTA
$1.89M
2
IMGN
Immunogen Inc
IMGN
$755K
3
STOK icon
Stoke Therapeutics
STOK
$744K
4
AXGN icon
Axogen
AXGN
$365K
5
SILK
Silk Road Medical, Inc. Common Stock
SILK
$325K

Top Sells

1
HROW icon
Harrow
HROW
$571K
2
IFRX icon
InflaRx
IFRX
$89.2K
3
NKTR icon
Nektar Therapeutics
NKTR
$51.8K
4
ELTX icon
Elicio Therapeutics
ELTX
$32K
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
$22K

Sector Composition

1 Healthcare 96.02%
2 Energy 3.95%
3 Consumer Staples 0.03%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
STOK icon
26
Stoke Therapeutics
STOK
$1.08B
$904K 0.68% 85,000 +70,000 +467% +$744K
VTYX icon
27
Ventyx Biosciences
VTYX
$171M
$866K 0.65% 26,400 – –
BLUE
28
DELISTED
bluebird bio
BLUE
$820K 0.61% 249,200 +50,000 +25% +$165K
CYTK icon
29
Cytokinetics
CYTK
$4.23B
$816K 0.61% 25,000 – –
PXD
30
DELISTED
Pioneer Natural Resource Co.
PXD
$787K 0.59% 3,800 – –
TXG icon
31
10x Genomics
TXG
$1.74B
$670K 0.5% 12,000 +2,000 +20% +$112K
SILK
32
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$650K 0.49% 20,000 +10,000 +100% +$325K
TVTX icon
33
Travere Therapeutics
TVTX
$1.56B
$614K 0.46% 40,000 +10,000 +33% +$154K
TSVT
34
DELISTED
2seventy bio
TSVT
$606K 0.45% 59,833 – –
KDNY
35
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$576K 0.43% 15,000 – –
KPTI icon
36
Karyopharm Therapeutics
KPTI
$61.7M
$521K 0.39% 291,332 – –
KNSA icon
37
Kiniksa Pharmaceuticals
KNSA
$2.48B
$422K 0.32% 30,000 – –
XENE icon
38
Xenon Pharmaceuticals
XENE
$2.98B
$385K 0.29% 10,000 – –
ARVN icon
39
Arvinas
ARVN
$568M
$372K 0.28% 15,000 – –
AXGN icon
40
Axogen
AXGN
$743M
$365K 0.27% +40,000 New +$365K
HALO icon
41
Halozyme
HALO
$8.56B
$361K 0.27% 10,000 – –
KALV icon
42
KalVista Pharmaceuticals
KALV
$678M
$360K 0.27% 40,000 – –
PGNY icon
43
Progyny
PGNY
$2.04B
$354K 0.27% 9,000 – –
FOLD icon
44
Amicus Therapeutics
FOLD
$2.34B
$352K 0.26% 28,000 – –
XNCR icon
45
Xencor
XNCR
$580M
$307K 0.23% 12,300 – –
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.78B
$286K 0.21% 2,500 – –
KROS icon
47
Keros Therapeutics
KROS
$618M
$281K 0.21% 7,000 – –
CGEM icon
48
Cullinan Oncology
CGEM
$445M
$270K 0.2% 25,114 – –
IFRX icon
49
InflaRx
IFRX
$108M
$223K 0.17% 50,000 -20,000 -29% -$89.2K
BCRX icon
50
BioCryst Pharmaceuticals
BCRX
$1.74B
$141K 0.11% 20,000 – –
1
2
3